Journal
BRAIN COMMUNICATIONS
Volume 2, Issue 2, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/braincomms/fcaa146
Keywords
inflammation; protein aggregation; tumour necrosis factor; induced pluripotent stem cells; presenilin-1
Categories
Funding
- Dementias Platform UK [MR/N013255/1]
- StemBANCC [115439]
- Alzheimer's Research UK [ARUK-SCRC2017-1]
- Wellcome Trust [101052/Z/13/Z, 105358/Z/14/Z, 203144]
- Cancer Research UK [C6946/A24843]
- European Research Council [669237]
- Royal Society
- MRC [MR/L023784/2, UKDRI-2003, MR/L023784/1] Funding Source: UKRI
Ask authors/readers for more resources
In addition to increased aberrant protein aggregation, inflammation has been proposed as a key element in the pathogenesis and progression of Alzheimer's disease. How inflammation interacts with other disease pathways and how protein aggregation increases during disease are not clear. We used single-molecule imaging approaches and membrane permeabilization assays to determine the effect of chronic exposure to tumour necrosis factor, a master proinflammatory cytokine, on protein aggregation in human-induced pluripotent stem cell-derived neurons harbouring monogenic Alzheimer's disease mutations. We report that exposure of Alzheimer's disease neurons, but not control neurons, to tumour necrosis factor induces substantial production of extracellular protein aggregates. Aggregates from Alzheimer's disease neurons are composed of amyloid-beta and alpha-synuclein and induce significant permeabilization of lipid membranes in an assay of pathogenicity. These findings provide support for a causal relationship between two crucial processes in Alzheimer's disease pathogenesis and suggest that targeting inflammation, particularly tumour necrosis factor, may have beneficial downstream effects on ameliorating aberrant protein aggregation and accumulation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available